Verdad Advisers, LP Organon & Co. Transaction History

Verdad Advisers, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$10.95 - $17.32 $118,259 - $187,056	-10,800 Reduced 60.67%	7,000 $100,000
Q3 2023 Nov 13, 2023	SELL	$16.59 - $23.77 $3,318 - $4,754	-200 Reduced 1.11%	17,800 $309,000
Q2 2023 Aug 09, 2023	BUY	$19.27 - $24.63 $346,860 - $443,340	18,000 New	18,000 $374,000

809

198M

1.84M

1.41M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $2.34B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Verdad Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Verdad Advisers, LP with notifications on news.